selected publications
-
Journal Article
- Average clinician-measured blood pressures and cardiovascular outcomes in patients with type 2 diabetes mellitus and ischemic heart disease in the EXAMINE Trial. Journal of the American Heart Association. 2018
- Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome. Clinical Cardiology. 2018
- Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial. JAMA internal medicine. 2017
- Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. Diabetes, Obesity & Metabolism. 2017
- Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin. Hypertension (Dallas, Tex.. 2016
- Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial. Diabetes care. 2016
- Orthostatic hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) blood pressure trial: prevalence, incidence, and prognostic significance. Hypertension (Dallas, Tex.. 2016
- Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes care. 2014
- Alogliptin after acute coronary syndrome in patients with type 2 diabetes. New England Journal of Medicine. 2013
- Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension (Dallas, Tex.. 2013
- Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney International. 2012
- Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hypertension: the ALLHAT Diabetes Extension Study. Circulation: Cardiovascular Quality and Outcomes. 2012
- EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. American Heart Journal. 2011
- Long-term effects of intensive glucose lowering on cardiovascular outcomes. New England Journal of Medicine. 2011
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (London, England). 2010
- Effects of combination lipid therapy in type 2 diabetes mellitus. New England Journal of Medicine. 2010
- Effects of intensive blood-pressure control in type 2 diabetes mellitus. New England Journal of Medicine. 2010
- Effects of medical therapies on retinopathy progression in type 2 diabetes. New England Journal of Medicine. 2010
- ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Archives of Internal Medicine. 2009
- Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine. 2008
- Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (Dallas, Tex.. 2007
-
Conference Paper
-
Review
- Blood pressure assessment in adults in clinical practice and clinic-based research: JACC Scientific Expert Panel [review]. Journal of the American College of Cardiology. 2019
- Research needs to improve hypertension treatment and control in African Americans [review]. Hypertension (Dallas, Tex.. 2016
-
Abstract
- Mortality findings from the EXAMINE Trial [abstract]. Diabetes. 2016
- Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract]. Diabetes. 2015
- Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. Diabetologia. 2011